3 tips for beating the stock market — from a fund manager who keeps doing it

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 81 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 36%
  • Publisher: 97%

United States News News

United States United States Latest News,United States United States Headlines

3 tips for beating the stock market — from a fund manager who keeps doing it (via Michael Brush)

With trading commissions approaching zero and cool mobile apps making the stock market look like just another video game, it’s more tempting than ever to “entertain” yourself with rapid-fire trading.

Once again, the buy-and-hold message comes through loud and clear. “We think our edge comes from having a longer-term orientation. We have a holding period of four or five years, if not longer,” says Chris Mack, who helps manage the fund. Consider Microsoft MSFT, -0.12% Its cloud efforts grab the headlines because this is one of the sexy areas of tech right now. But good old Microsoft Office, now called Microsoft Office 365, is a core source of growth. “Everyone questioned that a few years ago,” says Mack. That’s because cheap knockoffs seemed attractive. When even free products like competing software from Alphabet GOOG, +0.35% GOOGL, +0.33% fail to lure customers away, “that’s switching costs,” says Mack.

Mack is skeptical of one sector that has historically been a good place to hunt for the protective moat that comes from brand power: Consumer packaged goods. The brand power of companies like Nestlé NSRGY, +0.39% NESN, +0.27% is getting leveled by e-commerce. In a world where sales are migrating to Amazon.com AMZN, -0.08% the power of big brands to wrangle scarce shelf space in supermarket chains is less important than it used to be.

For Energizer Bunny growth, Mack also likes WuXi Biologics 2269, +1.01% which also trades over the counter. WuXi help biotech and pharma companies develop “biologics.” These are therapies manufactured via processes that involve living organisms and a lot trickier than mixing chemicals. Because developing biologics is so complicated, Mack thinks biotech and pharma companies will be outsourcing this kind of manufacturing more often.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Election jitters to keep India stock market on edge: Reuters pollHow Indian shares fare this year will depend heavily on the outcome of national ... Election jitters? Today? What about nuclear war jitters, do they have those too?
Source: Reuters - 🏆 2. / 97 Read more »

Investors don't understand just how important China is for European stocks, asset manager saysInvestors don't seem to understand the importance of China's economy for European stocks, particularly for Germany and Northern Europe, according to Philip Saunders, co-head of multi-asset at Investec Asset Management. Who are these “investors” with neither brains, nor AI ? Is that why Europe has turned a blind eye to their human rights abuses and kowtow like an eunuch these days? merkel is trash
Source: CNBC - 🏆 12. / 72 Read more »